T lymphocyte subsets in Mediterranean spotted fever
J I Herrero-Herrero1, R Ruiz-Beltrán, M Cordero
1Department of Medicine, University Hospital, Salamanca, Spain.
Acta Tropica
|September 1, 1988
Summary
Mediterranean spotted fever (MSF) patients showed a slight, transient reversal in T lymphocyte helper-inducer/suppressor-cytotoxic cell ratios during infection. This immune disturbance lacked clinical significance in the studied patients.
Area of Science:
- Immunology
- Infectious Diseases
- Microbiology
Background:
- Previous research suggests T lymphocyte suppressor cells may play a role in Rickettsia infections.
- Mediterranean spotted fever (MSF) is a significant rickettsial disease.
Purpose of the Study:
- To investigate T lymphocyte populations in patients with Mediterranean spotted fever (MSF).
- To assess changes in T lymphocyte subsets during the acute and convalescent phases of MSF.
Main Methods:
- Quantification of peripheral blood lymphocyte populations (CD3+, CD4+, CD8+, CD38+, CD20+) using monoclonal antibodies.
- Analysis of lymphocyte populations in 15 MSF patients during acute and convalescent disease phases.
Main Results:
- A reversal in the normal T lymphocyte helper-inducer/suppressor-cytotoxic cell ratio was observed in three out of 15 patients.
- This ratio disturbance was transient, lasting up to five weeks in two patients.
- The observed immune disturbance was consistently weak and did not correlate with clinical significance.
Conclusions:
- While a transient and weak reversal of T lymphocyte subsets can occur in MSF, it appears to lack clinical significance.
- The role of T lymphocyte suppressor populations in Rickettsia infections warrants further investigation.
More Related Videos
08:46Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
Published on: May 18, 2016
05:03Accessing Early Differentiation of Virus-Specific Follicular Helper CD4+ T Cell in Acute LCMV-Infected Mice
Published on: April 26, 2024
